Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget
Cancer is a complicated, deadly disease, ranking as the second leading cause of death globally. The World Health Organization (WHO) reported nearly 20 million new cases of cance...